Evidence map›Paper›PMID 38890356›Full record

ArticleCell death & disease2024

Sequestosome-1 (SQSTM1/p62) as a target in dopamine catabolite-mediated cellular dyshomeostasis.

Anna Masato, Annapaola Andolfo, Giulia Favetta, Edoardo Niccolò Bellini, Susanna Cogo, Luisa Dalla Valle, Daniela Boassa, Elisa Greggio, Nicoletta Plotegher, Luigi Bubacco

Abstract read
In one paragraph

Article in Cell death & disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anna MasatoDepartment of Biology, University of Padova, Padova, Italy.ORCID 0000-0003-4450-1838
Annapaola AndolfoProteomics and Metabolomics Facility (ProMeFa), Center for Omics Sciences (COSR), IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0002-0566-2391
Giulia FavettaDepartment of Biology, University of Padova, Padova, Italy.ORCID 0009-0002-2397-9218
Edoardo Niccolò BelliniProteomics and Metabolomics Facility (ProMeFa), Center for Omics Sciences (COSR), IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0001-9766-7685
Susanna CogoDepartment of Biology, University of Padova, Padova, Italy.
Luisa Dalla ValleDepartment of Biology, University of Padova, Padova, Italy.ORCID 0000-0001-8097-6369
Daniela BoassaDepartment of Neurosciences and National Center for Microscopy and Imaging Research, University of California San Diego, La Jolla, CA, USA.
Elisa GreggioDepartment of Biology, University of Padova, Padova, Italy.ORCID 0000-0002-8172-3598
Nicoletta PlotegherDepartment of Biology, University of Padova, Padova, Italy.
Luigi BubaccoDepartment of Biology, University of Padova, Padova, Italy. luigi.bubacco@unipd.it.ORCID 0000-0001-7927-9208

Funding

Università degli Studi di Padova (University of Padova) 123
6 · The paper itself

Abstract

Alterations in the dopamine catabolic pathway are known to contribute to the degeneration of nigrostriatal neurons in Parkinson's disease (PD). The progressive cellular buildup of the highly reactive intermediate 3,4-dihydroxyphenylacetaldehye (DOPAL) generates protein cross-linking, oligomerization of the PD-linked αSynuclein (αSyn) and imbalance in protein quality control. In this scenario, the autophagic cargo sequestome-1 (SQSTM1/p62) emerges as a target of DOPAL-dependent oligomerization and accumulation in cytosolic clusters. Although DOPAL-induced oxidative stress and activation of the Nrf2 pathway promote p62 expression, p62 oligomerization rather seems to be a consequence of direct DOPAL modification. DOPAL-induced p62 clusters are positive for ubiquitin and accumulate within lysosomal-related structures, likely affecting the autophagy-lysosomal functionality. Finally, p62 oligomerization and clustering is synergistically augmented by DOPAL-induced αSyn buildup. Hence, the substantial impact on p62 proteostasis caused by DOPAL appears of relevance for dopaminergic neurodegeneration, in which the progressive failure of degradative pathways and the deposition of proteins like αSyn, ubiquitin and p62 in inclusion bodies represent a major trait of PD pathology.

Indexed as

DopamineSequestosome-1 Proteinalpha-SynucleinAnimalsAutophagyDopaminergic NeuronsHumansLysosomesParkinson Diseasealpha-SynucleinDopamineSequestosome-1 ProteinSQSTM1 protein, human

Identifiers

PMID38890356
PMCPMC11189528

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.